Prot# SP792: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Five-Arm Parallel-Group Trial to Investigate the Efficacy and Safety of Four Different Transdermal Doses of Rotigotine in Subjects with Idiopathic Restless Legs Syndrome

Project: Research project

Project Details

StatusFinished
Effective start/end date7/27/053/11/08

Funding

  • Schwarz BioSciences Inc. (SP792)